465 related articles for article (PubMed ID: 33763422)
1. MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic.
Li WJ; Wang Y; Liu R; Kasinski AL; Shen H; Slack FJ; Tang DG
Front Cell Dev Biol; 2021; 9():640587. PubMed ID: 33763422
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development.
Li WJ; Liu X; Dougherty EM; Tang DG
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139695
[TBL] [Abstract][Full Text] [Related]
3. Nanovesicle-mediated systemic delivery of microRNA-34a for CD44 overexpressing gastric cancer stem cell therapy.
Jang E; Kim E; Son HY; Lim EK; Lee H; Choi Y; Park K; Han S; Suh JS; Huh YM; Haam S
Biomaterials; 2016 Oct; 105():12-24. PubMed ID: 27497057
[TBL] [Abstract][Full Text] [Related]
4. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Liu C; Kelnar K; Liu B; Chen X; Calhoun-Davis T; Li H; Patrawala L; Yan H; Jeter C; Honorio S; Wiggins JF; Bader AG; Fagin R; Brown D; Tang DG
Nat Med; 2011 Feb; 17(2):211-5. PubMed ID: 21240262
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of microRNAs that synergize with miR-34a - a basis for combinatorial microRNA therapeutics.
Orellana EA; Li C; Lisevick A; Kasinski AL
Cell Cycle; 2019 Aug; 18(15):1798-1811. PubMed ID: 31258013
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly.
Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
Theranostics; 2017; 7(19):4805-4824. PubMed ID: 29187905
[No Abstract] [Full Text] [Related]
7. The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas.
Adams BD; Parsons C; Slack FJ
Expert Opin Ther Targets; 2016 Jun; 20(6):737-53. PubMed ID: 26652031
[TBL] [Abstract][Full Text] [Related]
8.
Chen PC; Yu CC; Huang WY; Huang WH; Chuang YM; Lin RI; Lin JMJ; Lin HY; Jou YC; Shen CH; Chan MWY
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569404
[TBL] [Abstract][Full Text] [Related]
9. Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer.
Bonetti P; Climent M; Panebianco F; Tordonato C; Santoro A; Marzi MJ; Pelicci PG; Ventura A; Nicassio F
Oncogene; 2019 Jan; 38(3):360-374. PubMed ID: 30093634
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA regulation of cancer stem cells.
Liu C; Tang DG
Cancer Res; 2011 Sep; 71(18):5950-4. PubMed ID: 21917736
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
[TBL] [Abstract][Full Text] [Related]
12. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
Chen C; Bai L; Cao F; Wang S; He H; Song M; Chen H; Liu Y; Guo J; Si Q; Pan Y; Zhu R; Chuang TH; Xiang R; Luo Y
Oncogene; 2019 Jun; 38(23):4527-4539. PubMed ID: 30742065
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HOTAIR Promotes Cancer Stem-Like Cells Properties by Sponging miR-34a to Activate the JAK2/STAT3 Pathway in Pancreatic Ductal Adenocarcinoma.
Deng S; Wang J; Zhang L; Li J; Jin Y
Onco Targets Ther; 2021; 14():1883-1893. PubMed ID: 33737813
[TBL] [Abstract][Full Text] [Related]
14. microRNA-34a as a Therapeutic Agent against Human Cancer.
Saito Y; Nakaoka T; Saito H
J Clin Med; 2015 Nov; 4(11):1951-9. PubMed ID: 26580663
[TBL] [Abstract][Full Text] [Related]
15. Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential.
Nie D; Fu J; Chen H; Cheng J; Fu J
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781524
[TBL] [Abstract][Full Text] [Related]
16. Regorafenib suppresses colon tumorigenesis and the generation of drug resistant cancer stem-like cells via modulation of miR-34a associated signaling.
Cai MH; Xu XG; Yan SL; Sun Z; Ying Y; Wang BK; Tu YX
J Exp Clin Cancer Res; 2018 Jul; 37(1):151. PubMed ID: 30005681
[TBL] [Abstract][Full Text] [Related]
17. Expanding the Biotherapeutics Realm via miR-34a: "Potent Clever Little" Agent in Breast Cancer Therapy.
Mohammady M; Ghetmiri SI; Baharizade M; Morowvat MH; Torabi S
Curr Pharm Biotechnol; 2019; 20(8):665-673. PubMed ID: 31244419
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-34a overexpression inhibits multiple myeloma cancer stem cell growth in mice by suppressing TGIF2.
Wu S; He X; Li M; Shi F; Wu D; Pan M; Guo M; Zhang R; Luo S; Gu N; Dou J
Am J Transl Res; 2016; 8(12):5433-5443. PubMed ID: 28078014
[TBL] [Abstract][Full Text] [Related]
19. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
Sherman EJ; Mitchell DC; Garner AL
J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
